Conophylline Suppresses Angiotensin II-Induced Myocardial Fibrosis In Vitro via the BMP4/JNK Pathway
- 24 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bulletin of Experimental Biology and Medicine
- Vol. 171 (3), 305-311
- https://doi.org/10.1007/s10517-021-05217-0
Abstract
We studied the effects and mechanisms of action of conophylline in different concentrations in the original in vitro model of myocardial fibrosis (treatment of cardiac fibroblasts isolated form the hearts of newborn rats with angiotensin II). Viability, collagen content, and expression of related protein in cardiac fibroblasts were assessed using the MTT-test, Sircol assay, and Western blotting, respectively. Conophylline markedly protected the cultured cells against the development of angiotensin II-induced fibrosis, which was seen from reduced viability of fibroblasts, decreased collagen content, and down-regulation of the expression of α-smooth muscle actin (α-SMA). Conophylline did not affect the TGF-β pathway altered by angiotensin II, but markedly decreased the level of bone morphogenetic protein-4 (BMP4) enhanced by angiotensin II and BMP4 itself. Conophylline produced no effect on phosphorylation of α-SMA and Smad homologue-1/5/8, the classic BMP4 downstream pathway elements, but reduced the level of c-Jun N-terminal kinase (JNK) elevated by BMP4. Conophylline did not inhibit the development of myocardial fibrosis in the presence of JNK activator anisomycin. Thus, conophylline inhibited angiotensin II-provoked myocardial fibrosis via the BMP4/JNK pathway.Keywords
This publication has 15 references indexed in Scilit:
- SIRT3 inhibits Ang II-induced transdifferentiation of cardiac fibroblasts through β-catenin/PPAR-γ signalingLife Sciences, 2017
- Inhibition of the Cardiac Fibroblast–Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic DysfunctionCirculation Research, 2017
- Conophylline inhibits non-alcoholic steatohepatitis in micePLOS ONE, 2017
- Function and Therapeutic Potential of Noncoding RNAs in Cardiac FibrosisCirculation Research, 2016
- Bone morphogenetic protein-4: a novel therapeutic target for pathological cardiac hypertrophy/heart failureHeart Failure Reviews, 2014
- Conophylline suppresses hepatic stellate cells and attenuates thioacetamide-induced liver fibrosis in ratsLiver International, 2013
- Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts.Journal of Cardiovascular Translational Research, 2012
- Conophylline Suppresses Pancreatic Stellate Cells and Improves Islet Fibrosis in Goto-Kakizaki RatsEndocrinology, 2012
- Transforming growth factor (TGF)-β signaling in cardiac remodelingJournal of Molecular and Cellular Cardiology, 2011
- The pathology of hypertrophic cardiomyopathyHistopathology, 2004